mpo

  • 网络髓过氧化物酶;髓过氧化酶;微等离子体氧化
mpompo
  1. The activity of MPO was between 0.068 and 0.072 in the sham operation group .

    髓过氧化物酶活性:假手术组在0.068~0.072。

  2. Result of CFU-GM and MPO showed stimulating effects from extract of Angelica and Astragalus .

    粒单核祖细胞集落形成及髓过氧化物酶活性测定结果表明,当归和黄芪提取物具有促进粒单核细胞系列增殖的能力。

  3. Results Captopril could obviously inhibit MPO activity and ICAM-1 expression .

    结果卡托普利可明显抑制WPO活性及ICAM&1的表达。

  4. MPO 's value rised obviously on the first and third day after operation .

    术后1、3天MPO值明显上升。

  5. The activity of MPO in tissue was determinated by chemical measurement .

    采集组织标本测定MPO活性。

  6. The activity of myeloperoxidase ( MPO ) in liver tissue was also determined .

    测定肝组织中髓过氧化物酶(MPO)含量。

  7. Results Faint IL 1 β, MPO and ICAM 1 expression in control group ;

    结果对照组IL1β、MPO、ICAM1表达均微弱;

  8. Measure the MPO activity of the rest part of colon in homogenate .

    其余部分结肠组织匀浆测定MPO活性。

  9. The level of MPO was gradually increased in in liver and lung homogenate .

    肝、肺组织中的MPO活性增加;

  10. Effects of HBO exposure on MPO activity in pulmonary tissue homogenate of mice

    高压氧暴露对小鼠肺组织匀浆髓过氧化物酶活力的影响

  11. Then , the MPO activity in the pulmonary tissue homogenate was measured respectively .

    分别观察肺组织中MPO活力。

  12. There was a positive correlation between MPO and cerebral damage ( NSE activity ) .

    局灶性缺血脑组织中MPO活性与组织损伤(NSE活性)间具有高度正相关性。

  13. Blood LAA was positively correlated with tissue MPO content .

    外周血LAA与肺组织MPO含量呈正相关。

  14. Compared with model group , pulmonary MPO and intestinal MPO decreased significantly in prophylaxis group .

    与模型组相比,胆必清颗粒组肺、肠中的MPO明显降低。

  15. The changes of percutaneous oxygen pressure and MDA 、 MPO during ischemia-reperfusion in rat

    缺血再灌注期经皮氧分压与MDA、MPO的变化

  16. Effects of atorvastatin on P-selectin and MPO in cerebral ischemia reperfusion rats

    阿托伐他汀对鼠脑缺血再灌注后P-选择素、人髓过氧化物酶的影响

  17. Analysis on the effect of aluminium layer on interface stresses in HDA / MPO composite coatings

    铝层对热浸铝/等离子体电解氧化复合涂层界面应力的影响

  18. Both serum MPO ANCA and anti dsDNA became negative after treatment .

    血清MPOANCA和抗dsDNA均转为阴性。

  19. The MPO activity was significant increased in colitis tissue compared with normal group ( P0.001 ) .

    模型组大鼠结肠黏膜MPO水平较正常组明显增高(P0.001)。

  20. The secondary lysosomes and the small granules are strongly positive to MPO .

    次级溶酶体和小颗粒呈MPO强阳性。

  21. The Effects on Anti-oxidation System and the Expression of MPO Gene on Rat Skin and Organs by Arsenic

    砷对大鼠皮肤和脏器中抗氧化系统及MPO基因表达的影响

  22. Myeloperoxidase ( MPO ) in liver was measured by enzyme chemistry assay .

    酶化学法测定肝组织髓过氧化物酶(MPO)活性;

  23. Changes of ICAM-1 , Mac-1 and MPO Activity in Focal Cerebral Ischemic Mice

    小鼠局灶性脑缺血后ICAM-1、Mac-1和MPO活性的变化

  24. Morphology , cytochemistry , immunology classification and MPO mRNA expressions of acute leukemia

    急性白血病的形态、细胞化学、免疫分型及MPOmRNA表达

  25. Investigation of Ginsenoside on human PMN phagocytosis by Cl and MPO

    用CL法和微量MPO法观察人参皂甙对人PMN吞噬杀菌作用

  26. Effect of atorvastatin on MPO and PPAR γ expressed by monocyte

    阿托伐他汀对单核细胞髓过氧化物酶和过氧化物增殖活化剂受体γ表达的影响

  27. Neutrophil accumulation was determined by measuring myeloperoxidase ( MPO ) activity . 8 .

    用比色法测定髓过氧化酶(MPO)活性反映中性粒细胞粘附程度。

  28. The Effects of Atorvastatin and Aspirin on MPO and SOD in Rats Following Cerebral Ischemic Reperfusion

    阿托伐他汀与阿司匹林对大鼠脑缺血再灌注后MPO、SOD影响的研究

  29. Objective To evaluate the association between serum myeloperoxidase ( MPO ) level and coronary plaque vulnerability .

    目的探讨冠状动脉内粥样硬化斑块不同稳定程度患者的血清髓过氧化物酶(myeloperoxidase,MPO)水平的变化。

  30. Results Astragalus Atractylodes Decoction and its effective parts of the MPO activity in mice modeling have a certain effect ;

    结果白术黄芪汤及其有效成分对造模小鼠的MPO活性均有一定疗效;